2015Unpublished venueRequires access

Acupuncture at five-zang back-shu points and Geshu for depression: a randomized controlled trial

Yan Yang

Open publisher page 2 citations

Abstract

Objective To observe the efficacy and adverse reaction of acupuncture at five-zang back-shu points and Geshu for depression,so as to provide references for the clinical treatment of depression. Methods Sixty patients of depression were randomly divided into a treatment group and a control group,30 cases in each one. Patients in the treatment group were treated with acupuncture at five-zang back-shu points and Geshu,while patients in the control group were treated with oral administration of Citalopram. HAMD was observed before treatment,1,2,4,8 weeks into treatment and 12 weeks after treatment,also clinical cured rate and adverse reaction were recorded. Results At each time point during treatment period,the HAMD and each factor were significantly reduced( P 0. 05 or P 0. 01),and the difference between two groups was not significant( P 0. 05),indicating the two methods were both effective with similar short-term efficacy. 12 weeks after treatment,the cured rate was 77. 8% in the treatment group and 75. 0% in the control group,and the difference between two groups was not significant( P 0. 05),indicating the two methods had similar longterm efficacy. During the trial,1 patient in the treatment group had adverse reaction,which was significantly lower to 4 patients in the control group. Conclusion The efficacy of acupuncture at five-zang back-shu points and Geshu was similar to that of Citalopram.However,acupuncture takes effect more quickly,and has better improvement on anxiety / somatization,sleep disorder and cognitive disorder than western medication. Besides,acupuncture adverse reaction is less,safety is high and patient compliance is satisfactory.

About this research paper

What this paper is about

Objective To observe the efficacy and adverse reaction of acupuncture at five-zang back-shu points and Geshu for depression,so as to provide references for the clinical treatment of depression. Methods Sixty patients of depression were randomly divided into a treatment group and a control group,30 cases in each one. Patients in the treatment group were treated with acupuncture at five-zang back-shu points and Geshu,while patients in the control group were treated with oral administration of Citalopram. HAMD was observed before treatment,1,2,4,8 weeks into treatment and 12 weeks after treatment,also clinical cured rate and adverse reaction were recorded. Results At each time point during treatment period,the HAMD and each factor were significantly reduced( P 0. 05 or P 0. 01),and the difference between two groups was not significant( P 0. 05),indicating the two methods were both effective with similar short-term efficacy. 12 weeks after treatment,the cured rate was 77. 8% in the treatment group and 75. 0% in the control group,and the difference between two groups was not significant( P 0. 05),indicating the two methods had similar longterm efficacy. During the trial,1 patient in the treatment group had adverse reaction,which was significantly lower to 4 patients in the control group. Conclusion The efficacy of acupuncture at five-zang back-shu points and Geshu was similar to that of Citalopram.However,acupuncture takes effect more quickly,and has better improvement on anxiety / somatization,sleep disorder and cognitive disorder than western medication. Besides,acupuncture adverse reaction is less,safety is high and patient compliance is satisfactory.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy and adverse reaction of acupuncture at five-zang back-shu points and Geshu for depression,so as to provide references for the clinical treatment of depression. Methods Sixty patients of depression were randomly divided into a treatment group and a control group,30 cases in each one. Patients in the treatment group were treated with acupuncture at five-zang back-shu points and Geshu,while patients in the control group were treated with oral administration of Citalopram. HAMD was observed before treatment,1,2,4,8 weeks into treatment and 12 weeks after treatment,also clinical cured rate and adverse reaction were recorded. Results At each time point during treatment period,the HAMD and each factor were significantly reduced( P 0. 05 or P 0. 01),and the difference between two groups was not significant( P 0. 05),indicating the two methods were both effective with similar short-term efficacy. 12 weeks after treatment,the cured rate was 77. 8% in the treatment group and 75. 0% in the control group,and the difference between two groups was not significant( P 0. 05),indicating the two methods had similar longterm efficacy. During the trial,1 patient in the treatment group had adverse reaction,which was significantly lower to 4 patients in the control group. Conclusion The efficacy of acupuncture at five-zang back-shu points and Geshu was similar to that of Citalopram.However,acupuncture takes effect more quickly,and has better improvement on anxiety / somatization,sleep disorder and cognitive disorder than western medication. Besides,acupuncture adverse reaction is less,safety is high and patient compliance is satisfactory.

Key concepts: Medicine, Hamd, Acupuncture, Somatization, Depression (economics), Randomized controlled trial, Adverse effect, Treatment and control groups

Related papers

Back to paper searchBrowse research topicsOriginal source
Acupuncture at five-zang back-shu points and Geshu for depression: a randomized controlled trial — Research Paper | ScholarLens